{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T23:38:01Z","timestamp":1794526681787,"version":"4.9.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81960450"],"award-info":[{"award-number":["81960450"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The science and technology innovation Program of Changde city","award":["2024ZD115"],"award-info":[{"award-number":["2024ZD115"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14240-7","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T07:12:43Z","timestamp":1747033963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Platelet-albumin-bilirubin versus albumin\u2013bilirubin as a predictor of long-term survival for hepatitis B-Induced hepatocellular carcinoma after hepatic resection"],"prefix":"10.1186","volume":"25","author":[{"given":"Haojie","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangde","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"issue":"3","key":"14240_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-CANCER J CLIN. 2024;74(3):229\u201363.","journal-title":"CA-CANCER J CLIN"},{"issue":"3","key":"14240_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jhep.2014.10.037","volume":"62","author":"A Vitale","year":"2015","unstructured":"Vitale A, Burra P, Frigo AC, Trevisani F, Farinati F, Spolverato G, Volk M, Giannini EG, Ciccarese F, Piscaglia F, et al. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona clinic liver Cancer stages: a multicentre study. J HEPATOL. 2015;62(3):617\u201324.","journal-title":"J HEPATOL"},{"key":"14240_CR3","doi-asserted-by":"crossref","unstructured":"Zhou J, Sun H, Cong W, Zhou W, Bie P, Liu L, Wen T, Kuang M, Han G, Yan Z et al. Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition). Liver cancer (Basel) 2023, 12(5):405\u2013444.","DOI":"10.1159\/000530495"},{"issue":"10360","key":"14240_CR4","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345\u201362.","journal-title":"Lancet"},{"issue":"1","key":"14240_CR5","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1186\/s12967-024-05726-2","volume":"22","author":"Y Zhai","year":"2024","unstructured":"Zhai Y, Hai D, Zeng L, Lin C, Tan X, Mo Z, Tao Q, Li W, Xu X, Zhao Q, et al. Artificial intelligence-based evaluation of prognosis in cirrhosis. J TRANSL MED. 2024;22(1):933.","journal-title":"J TRANSL MED"},{"issue":"6","key":"14240_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, O\u2019Beirne J, Fox R, Skowronska A, Palmer D, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J CLIN ONCOL. 2015;33(6):550\u20138.","journal-title":"J CLIN ONCOL"},{"issue":"7","key":"14240_CR7","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/jgh.13291","volume":"31","author":"AW Chan","year":"2016","unstructured":"Chan AW, Kumada T, Toyoda H, Tada T, Chong CC, Mo FK, Yeo W, Johnson PJ, Lai PB, Chan AT, et al. Integration of albumin-bilirubin (ALBI) score into Barcelona clinic liver Cancer (BCLC) system for hepatocellular carcinoma. J GASTROEN HEPATOL. 2016;31(7):1300\u20136.","journal-title":"J GASTROEN HEPATOL"},{"issue":"5","key":"14240_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/jgh.13250","volume":"31","author":"A Hiraoka","year":"2016","unstructured":"Hiraoka A, Kumada T, Michitaka K, Toyoda H, Tada T, Ueki H, Kaneto M, Aibiki T, Okudaira T, Kawakami T, et al. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma. J GASTROEN HEPATOL. 2016;31(5):1031\u20136.","journal-title":"J GASTROEN HEPATOL"},{"issue":"1","key":"14240_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/jgh.13457","volume":"32","author":"AW Chan","year":"2017","unstructured":"Chan AW, Chong CC, Mo FK, Wong J, Yeo W, Johnson PJ, Yu S, Lai PB, Chan AT, To KF, et al. Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma. J GASTROEN HEPATOL. 2017;32(1):221\u20138.","journal-title":"J GASTROEN HEPATOL"},{"issue":"10","key":"14240_CR10","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1111\/jgh.13339","volume":"31","author":"AW Chan","year":"2016","unstructured":"Chan AW, Chong CC, Mo FK, Wong J, Yeo W, Johnson PJ, Yu S, Lai PB, Chan AT, To KF, et al. Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma. J GASTROEN HEPATOL. 2016;31(10):1766\u201372.","journal-title":"J GASTROEN HEPATOL"},{"key":"14240_CR11","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.2147\/JHC.S465962","volume":"11","author":"Y Xiong","year":"2024","unstructured":"Xiong Y, Qiao W, Mei T, Li K, Jin R, Zhang Y. Recurrence of hepatocellular carcinoma in patients with low Albumin-Bilirubin grade in TACE combined with ablation: A random forest Cox predictive model. J HEPATOCELL CARCINO. 2024;11:1375\u201388.","journal-title":"J HEPATOCELL CARCINO"},{"issue":"5","key":"14240_CR12","doi-asserted-by":"publisher","first-page":"100347","DOI":"10.1016\/j.jhepr.2021.100347","volume":"3","author":"CO Demirtas","year":"2021","unstructured":"Demirtas CO, D\u2019Alessio A, Rimassa L, Sharma R, Pinato DJ. ALBI grade: evidence for an improved model for liver functional Estimation in patients with hepatocellular carcinoma. JHEP REP. 2021;3(5):100347.","journal-title":"JHEP REP"},{"issue":"4","key":"14240_CR13","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/jgh.13608","volume":"32","author":"P Liu","year":"2017","unstructured":"Liu P, Hsu C, Hsia C, Lee Y, Chiou Y, Huang Y, Lee F, Lin H, Hou M, Huo T. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD era. J GASTROEN HEPATOL. 2017;32(4):879\u201386.","journal-title":"J GASTROEN HEPATOL"},{"key":"14240_CR14","doi-asserted-by":"publisher","first-page":"914997","DOI":"10.3389\/fonc.2022.914997","volume":"12","author":"R Liu","year":"2022","unstructured":"Liu R, Li R, Zhang M, Liu W, Li H, Li D. Prognostic value of Platelet-Albumin-Bilirubin grade in Child-Pugh A and B patients with hepatocellular carcinoma: A Meta-Analysis. FRONT ONCOL. 2022;12:914997.","journal-title":"FRONT ONCOL"},{"key":"14240_CR15","doi-asserted-by":"crossref","unstructured":"Hermanek P, Wittekind C. The pathologist and the residual tumor (R) classification, vol. 190; 1994.","DOI":"10.1016\/S0344-0338(11)80700-4"},{"issue":"3","key":"14240_CR16","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J. M Sherman 2011 Management of hepatocellular carcinoma: an update. Hepatology 53 3 1020\u20132.","journal-title":"Hepatology"},{"issue":"8","key":"14240_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. BRIT J SURG. 1973;60(8):646\u20139.","journal-title":"BRIT J SURG"},{"issue":"3","key":"14240_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","volume":"19","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. SEMIN LIVER DIS. 1999;19(3):329\u201338.","journal-title":"SEMIN LIVER DIS"},{"key":"14240_CR19","doi-asserted-by":"crossref","unstructured":"A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. HEPATOLOGY. 1998, 28(3):751\u2013755.","DOI":"10.1002\/hep.510280322"},{"issue":"7","key":"14240_CR20","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","volume":"146","author":"T Yau","year":"2014","unstructured":"Yau T, Tang VY, Yao TJ, Fan ST, Lo CM, Poon RT. Development of Hong Kong liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology. 2014;146(7):1691\u2013700.","journal-title":"Gastroenterology"},{"issue":"1","key":"14240_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1055\/s-2008-1040325","volume":"28","author":"F Durand","year":"2008","unstructured":"Durand F, Valla D. Assessment of prognosis of cirrhosis. SEMIN LIVER DIS. 2008;28(1):110\u201322.","journal-title":"SEMIN LIVER DIS"},{"issue":"Suppl1","key":"14240_CR22","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.jhep.2004.11.015","volume":"42","author":"F Durand","year":"2005","unstructured":"Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J HEPATOL. 2005;42(Suppl1):S100\u20137.","journal-title":"J HEPATOL"},{"issue":"1","key":"14240_CR23","doi-asserted-by":"publisher","first-page":"20739","DOI":"10.1038\/s41598-023-48068-7","volume":"13","author":"M Ninomiya","year":"2023","unstructured":"Ninomiya M, Tsuruoka M, Inoue J, Hiraoka A, Iwata T, Sano A, Sato K, Onuki M, Sawahashi S, Kuroda H, et al. A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage. SCI REP-UK. 2023;13(1):20739.","journal-title":"SCI REP-UK"},{"issue":"3","key":"14240_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, Ferrer-F\u00e0brega J, Burrel M, Garcia-Criado \u00c1, Kelley RK, Galle PR, Mazzaferro V, Salem R, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J HEPATOL. 2022;76(3):681\u201393.","journal-title":"J HEPATOL"},{"issue":"1","key":"14240_CR25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12876-024-03387-5","volume":"24","author":"M Kohla","year":"2024","unstructured":"Kohla M, Ashour R, Taha H, El-Abd O, Osman M, Abozeid M, ELKhadry SW. Prognostic performance of Hong Kong liver Cancer with Barcelona clinic liver Cancer staging systems in hepatocellular carcinoma. BMC GASTROENTEROL. 2024;24(1):318.","journal-title":"BMC GASTROENTEROL"},{"issue":"5","key":"14240_CR26","doi-asserted-by":"publisher","first-page":"e27355","DOI":"10.1016\/j.heliyon.2024.e27355","volume":"10","author":"S Jia-Yong","year":"2024","unstructured":"Jia-Yong S, Hong-Liang W, Ding-Wen L, Qing-Qing C, Yu-Tong C, Jun-Shao T, Mei C, Wei T, Rong-Wei X, Liang M, et al. Comparison of post-resection survival between hepatocellular carcinoma patients in BCLC stage A or B who experience tumor rupture and patients in BCLC stage C who do not. HELIYON. 2024;10(5):e27355.","journal-title":"HELIYON"},{"issue":"2","key":"14240_CR27","doi-asserted-by":"publisher","first-page":"109461","DOI":"10.1016\/j.ejso.2024.109461","volume":"51","author":"T Takamoto","year":"2025","unstructured":"Takamoto T, Nara S, Ban D, Mizui T, Mukai M, Esaki M, Shimada K. Chronological evolution in liver resection for hepatocellular carcinoma: prognostic trends across three decades in early to advanced stages. EJSO-EUR J SURG ONC. 2025;51(2):109461.","journal-title":"EJSO-EUR J SURG ONC"},{"issue":"1","key":"14240_CR28","doi-asserted-by":"publisher","first-page":"22588","DOI":"10.1038\/s41598-024-72767-4","volume":"14","author":"Y Ding","year":"2024","unstructured":"Ding Y, Chang T, Shen C, Kuo L, Hsu S, Chen Y, Hsieh Y, Huang H, Lu S. Survival benefit of sequential curative treatment for TACE suitable BCLC stage B HCC patients. SCI REP-UK. 2024;14(1):22588.","journal-title":"SCI REP-UK"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14240-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14240-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14240-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T19:04:40Z","timestamp":1747076680000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14240-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14240"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14240-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All study participants, or their legal guardian, provided informed written consent prior to study enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Technical appendix, statistical code, and dataset are available from yhj643607891@163.com. Participants gave informed consent for data sharing.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data sharing statement"}},{"value":"The study was reviewed and approved by Guangxi Medical University Cancer Hospital and Changde Hospital (The First People\u2019s Hospital of Changde), Xiangya School of Medicine, Central South University.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"855"}}